-
Review
January 22, 2025
- Unveiling the intratumor microbiome in liver cancer: Current insights and prospective applications
- Xindi Ke, Shangze Jiang, Qiaoxin Wei, et al.
- Clin Mol Hepatol. 2025;31(3):685-705.
- Special Review
- Liver disease trends in the Asia-Pacific region for the next 50 years
- Shuichiro Shiina, Javkhlan Maikhuu, Qing Deng, Terguunbileg Batsaikhan, Lariza Marie Canseco, Maki Tobari, Hitoshi Maruyama, Hiroaki Nagamatsu, Diana Alcantara-Payawal, Rino Gani, Yi-Hsiang Huang, Tawesak Tanwandee, Giovanni Galati, Yoon Jun Kim
- Clin Mol Hepatol. 2025;31(3):671-684. Published online March 4, 2025
-
View: 1519 Download: 121 Crossref: 1

- Review
- Unveiling the intratumor microbiome in liver cancer: Current insights and prospective applications
- Xindi Ke, Shangze Jiang, Qiaoxin Wei, Minghao Sun, Hang Sun, Mingchang Pang, Mei Liu, Lejia Sun, Huayu Yang, Yilei Mao
- Clin Mol Hepatol. 2025;31(3):685-705. Published online January 22, 2025
-
View: 1775 Download: 195 Crossref: 1

- Deciphering adenosine signaling in hepatocellular carcinoma: Pathways, prognostic models, and therapeutic implications
- Huihai Yang, Martina Mang Leng Lei, Longfei Xie, Yinuo Shou, Terence Kin Wah Lee
- Clin Mol Hepatol. 2025;31(3):706-729. Published online February 5, 2025
-
View: 1777 Download: 152 Crossref: 1

- Tracking the trajectory of kidney dysfunction in cirrhosis: the acute kidney injury: chronic kidney disease spectrum
- Vishnu Girish, Rakhi Maiwall
- Clin Mol Hepatol. 2025;31(3):730-752. Published online March 26, 2025
-
View: 1249 Download: 153

- Emerging therapies and real-world application of metabolic dysfunction-associated steatotic liver disease treatment
- Hee Yeon Kim, Mary E. Rinella
- Clin Mol Hepatol. 2025;31(3):753-770. Published online April 2, 2025
-
View: 1670 Download: 185 Crossref: 1

- Role of amino acids in the regulation of hepatic gluconeogenesis and lipogenesis in metabolic dysfunctionassociated steatotic liver disease
- Eiji Kakazu, Masaaki Mino, Tatsuya Kanto
- Clin Mol Hepatol. 2025;31(3):771-795. Published online April 16, 2025
-
View: 1379 Download: 159 Crossref: 1

- Original Article
- High Steatosis-Associated Fibrosis Estimator scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction-associated steatotic liver disease
- Tung-Hung Su, Sheng-Shun Yang, Mei-Hsuan Lee, Wei-Yu Kao, Shang-Chin Huang, Fen-Fang Chen, Francis SK Poon, Lung-Wen Tsai, Yi-Ting Chen, Che Lin, Weichung Wang, W Ray Kim, Jia-Horng Kao
- Clin Mol Hepatol. 2025;31(3):796-809. Published online January 6, 2025
-
View: 1885 Download: 200

- Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial
- Hyung Joon Yim, Yeon Seok Seo, Ji Hoon Kim, Won Kim, Young Kul Jung, Jae Young Jang, Sae Hwan Lee, Yun Soo Kim, Chang Wook Kim, Hyoung Su Kim, Jae-Jun Shim, Eun-Young Cho, In Hee Kim, Byung Seok Lee, Jeong-Hoon Lee, Byung Seok Kim, Jeong Won Jang, Hyun Woong Lee, Jung Hyun Kwon, Moon Young Kim, Do Seon Song, Jung Gil Park, Yoon Seok Lee, Eileen L. Yoon, Han Ah Lee, Seong Hee Kang, Jin Mo Yang
- Clin Mol Hepatol. 2025;31(3):810-822. Published online January 17, 2025
-
View: 2105 Download: 97 Crossref: 1

- Modulation of phosphatase of regenerating liver-1 within placental mesenchymal stem cells instigates the transition between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition subsequent to hepatic fibrosis
- Jae Yeon Kim, Hyeri Park, Soo Young Park, Se Ho Kim, Ja Yun Lim, Ki Seog Lee, Si Hyun Bae, Gi Jin Kim
- Clin Mol Hepatol. 2025;31(3):823-840. Published online January 22, 2025
-
View: 4959 Download: 844

- Glutamate dehydrogenase 1-dependent α-ketoglutarate promotes hepatitis B virus transcription by modulating histone methylations on the covalently closed circular DNA minichromosome
- Sheng-Tao Cheng, Wei-Xian Chen, Hai-Jun Deng, Xin He, Hui Zhang, Ming Tan, Hai-Bo Yu, Zhen-Zhen Zhang, Ji-Hua Ren, Min-Li Yang, Da-Peng Zhang, Zhi-Hong Li, Juan Chen
- Clin Mol Hepatol. 2025;31(3):841-865. Published online February 5, 2025
-
View: 1804 Download: 281

- Baveno VI-SSM stratifies the risk of portal hypertensionrelated events in patients with HBV-related cirrhosis
- Haiyu Wang, Weihao Liang, Ling Zhou, Jiankang Song, Biao Wen, Qiaoping Wu, Yuanjian Zhang, Xiaofeng Zhang, Haoran Ke, Yujun Tang, Fuyuan Zhou, Youfu Zhu, Weiqun Wen, Zhihua Liu, Yali Ji, Qintao Lai, Qinjun He, Wenfan Luo, Tingting Qi, Miaoxia Liu, Xiaoqin Lan, Yongpeng Chen, Ranran Xi, Junting Wan, Lin Dai, Yuan Li, Jinjun Chen
- Clin Mol Hepatol. 2025;31(3):866-880. Published online February 5, 2025
-
View: 1347 Download: 137

- Fibrosis-4plus score: a novel machine learning-based tool for screening high-risk varices in compensated cirrhosis (CHESS2004): an international multicenter study
- Bingtian Dong, Ruiling He, Shenghong Ju, Yuping Chen, Ivica Grgurevic, Jianzhong Ma, Ying Guo, Huizhen Fan, Qiang Yan, Chuan Liu, Huixiong Xu, Anita Madir, Kristian Podrug, Jia Wang, Linxue Qian, Zhengzi Geng, Shanghao Liu, Tao Ren, Guo Zhang, Kun Wang, Meiqin Su, Fei Chen, Sumei Ma, Liting Zhang, Zhaowei Tong, Yonghe Zhou, Xin Li, Fanbin He, Hui Huan, Wenjuan Wang, Yunxiao Liang, Juan Tang, Fang Ai, Tingyu Wang, Liyun Zheng, Zhongwei Zhao, Jiansong Ji, Wei Liu, Jiaojiao Xu, Bo Liu, Xuemei Wang, Yao Zhang, Qiong Yan, Hui Liu, Xiaomei Chen, Shuhua Zhang, Yihua Wang, Yang Liu, Li Yin, Yanni Liu, Yanqing Huang, Li Bian, Ping An, Xin Zhang, Shaoting Zhang, Jinhua Shao, Xiangman Zhang, Wei Rao, Chaoxue Zhang, Christoph Frank Dietrich, Won Kim, Xiaolong Qi
- Clin Mol Hepatol. 2025;31(3):881-898. Published online February 5, 2025
-
View: 2641 Download: 205

- Direct-acting antiviral therapy for patients with hepatitis C virus-related hepatocellular carcinoma: A nationwide cohort study
- Shou-Wu Lee, Sheng-Shun Yang, Pei-Chien Tsai, Chung-Feng Huang, Chi-Yi Chen, Chao-Hung Hung, Chien-Hung Chen, Chi-Ming Tai, Pin-Nan Cheng, Hsing-Tao Kuo, Kuo-Chih Tseng, Lein-Ray Mo, Ching-Chu Lo, Yi-Hsiang Huang, Han-Chieh Lin, Pei-Lun Lee, Ming-Jong Bair, Te-Sheng Chang, Chun-Yen Lin, Szu-Jen Wang, Tsai-Yuan Hsieh, Tzeng-Hue Yang, Cheng-Yuan Peng, Chi-Chieh Yang, Lee-Won Chong, Chien-Wei Huang, Chih-Wen Lin, Cheng-Hsin Chu, Ming-Chang Tsai, Jia-Horng Kao, Chun-Jen Liu, Wan-Long Chuang, Teng-Yu Lee, Ming-Lung Yu, on behalf of TACR investigators
- Clin Mol Hepatol. 2025;31(3):899-913. Published online February 5, 2025
-
View: 2364 Download: 153

- GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma
- Hyung Seok Kim, Jung Hwan Yoon, Ji Yi Choi, Moon Gyeong Yoon, Geum Ok Baek, Minji Kang, Se Ha Jang, Won Park, Yunjin Go, Jestlin Tianthing Ng, Suk Woo Nam, Jee-Yeong Jeong, Ji Eun Han, Hyo Jung Cho, Su Bin Lim, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun
- Clin Mol Hepatol. 2025;31(3):914-934. Published online February 6, 2025
-
View: 3488 Download: 857 Crossref: 2

- Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target
- Gu-Wei Ji, Zheng-Gang Xu, Shuo-Chen Liu, Shu-Ya Cao, Chen-Yu Jiao, Ming Lu, Biao Zhang, Yue Yang, Qing Xu, Xiao-Feng Wu, Ke Wang, Yong-Xiang Xia, Xiang-Cheng Li, Xue-Hao Wang
- Clin Mol Hepatol. 2025;31(3):935-959. Published online February 10, 2025
-
View: 7601 Download: 353

- CD36 promotes iron accumulation and dysfunction in CD8+ T cells via the p38-CEBPB-TfR1 axis in earlystage hepatocellular carcinoma
- Yifei Qin, Fei Huo, Zhuan Feng, Jialu Hou, Yaxin Ding, Quancheng Wang, Yu Gui, Ziwei Yang, Jiali Yang, Gang Zhou, Ling Li, Jianli Jiang, Lingmin Kong, Shijie Wang, Gang Nan, Dingqiao Xu, Xiaohang Xie, Lijuan Wang, Qian He, Ruibin Yang, Peng Lin, Huijie Bian, Zhi-Nan Chen, Jiao Wu
- Clin Mol Hepatol. 2025;31(3):960-980. Published online March 4, 2025
-
View: 1773 Download: 291

- Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway
- Tomoko Aoki, Naoshi Nishida, Yutaka Kurebayashi, Kazuko Sakai, Naoto Fujiwara, Masakatsu Tsurusaki, Kohei Hanaoka, Masahiro Morita, Hirokazu Chishina, Masahiro Takita, Satoru Hagiwara, Hiroshi Ida, Kazuomi Ueshima, Yasunori Minami, Atsushi Takebe, Takaaki Murase, Keiko Kamei, Takuya Nakai, Ippei Matsumoto, Kazuto Nishio, Masatoshi Kudo
- Clin Mol Hepatol. 2025;31(3):981-1002. Published online March 11, 2025
-
View: 2073 Download: 221

- Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues
- Rui Huang, Dae Won Jun, Hidenori Toyoda, Yao-Chun Hsu, Huy Trinh, Akito Nozaki, Toru Ishikawa, Tsunamasa Watanabe, Haruki Uojima, Daniel Q. Huang, Takashi Honda, Yasuhito Tanaka, Philip Vutien, Sebastián Marciano, Hiroshi Abe, Masaru Enomoto, Masanori Atsukawa, Hirokazu Takahashi, Kunihiko Tsuji, Koichi Takaguchi, Pei-Chien Tsai, Chia-Yen Dai, Jee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, Eileen Yoon, Sung Eun Kim, Sang Bong Ahn, Gi-Ae Kim, Jang Han Jung, Soung Won Jeong, Hyunwoo Oh, Cheng-Hao Tseng, Masatoshi Ishigami, Angela Chau, Mayumi Maeda, Satoshi Yasuda, Makoto Chuma, Takanori Ito, Keigo Kawashima, Joanne Kimiko Liu, Adrian Gadano, Ritsuzo Kozuka, Norio Itokawa, Kaori Inoue, Tomonori Senoh, Jie Li, Wan-Long Chuang, Ramsey Cheung, Chao Wu, Ming-Lung Yu, Mindie H. Nguyen
- Clin Mol Hepatol. 2025;31(3):1003-1017. Published online March 17, 2025
-
View: 2099 Download: 149 Crossref: 1

- Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease
- Hye Won Lee, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
- Clin Mol Hepatol. 2025;31(3):1018-1031. Published online April 4, 2025
-
View: 1151 Download: 124

- MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation
- Tiantian Wang, Dean Rao, Chenan Fu, Zhoubin Sun, Yiming Luo, Junli Lu, Jie Jin, Han Li, Feimu Fan, Huifang Liang, Wenjie Huang, Limin Xia
- Clin Mol Hepatol. 2025;31(3):1032-1057. Published online April 11, 2025
-
View: 1742 Download: 244

- Sex disparities in alcohol-associated liver disease and subtype differences in alcohol-attributable cancers in the United States
- Pojsakorn Danpanichkul, Yanfang Pang, Tanuj Mahendru, Primrose Tothanarungroj, Luis Antonio Díaz, Juan Pablo Arab, Pimtawan Jatupornpakdee, Mark D. Muthiah, Kwanjit Duangsonk, Won-Mook Choi, Daniel Q. Huang, Donghee Kim, Mazen Noureddin, Karn Wijarnpreecha, Suthat Liangpunsakul, Amit G. Singal, Ju Dong Yang
- Clin Mol Hepatol. 2025;31(3):1058-1070. Published online April 11, 2025
-
View: 1748 Download: 100

- HTD1801 demonstrates promising potential for histologic improvements in metabolic dysfunction-associated steatohepatitis in both a preclinical and phase 2 study
- Vincent Wai-Sun Wong, Guy W. Neff, Adrian M. Di Bisceglie, Ru Bai, Junwei Cheng, Meng Yu, Alexander Liberman, Liping Liu, Nadege Gunn
- Clin Mol Hepatol. 2025;31(3):1071-1083. Published online April 21, 2025
-
View: 951 Download: 57

- Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study
- Xianhua Mao, Xinrong Zhang, Rongtao Lai, Ka-Shing Cheung, Man-Fung Yuen, Ramsey Cheung, Wai-Kay Seto, Mindie H. Nguyen
- Clin Mol Hepatol. 2025;31(3):1084-1099. Published online April 23, 2025
-
View: 1621 Download: 166

- Snapshot
- Interventions targeting the gut-liver axis: A potential treatment strategy for metabolic dysfunction-associated steatotic liver disease
- Pingping Jin, Xinyi Lu, Daozhen Chen, Yu Chen
- Clin Mol Hepatol. 2025;31(3):1100-1102. Published online February 6, 2025
-
View: 938 Download: 103

- Erratum
- Erratum to ‘Systemic therapy in advanced hepatocellular carcinoma’ [Clin Mol Hepatol 2023;29:516-519]
- Joseph C. Ahn, Nguyen H. Tran, Ju Dong Yang
- Clin Mol Hepatol. 2025;31(3):1103-1104. Published online July 1, 2025
-
View: 323 Download: 5

- Erratum to ‘Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study’ [Clin Mol Hepatol 2024;30:487-499]
- Seogsong Jeong, Yun Hwan Oh, Joseph C Ahn, Seulggie Choi, Sun Jae Park, Hye Jun Kim, Gyeongsil Lee, Joung Sik Son, Heejoon Jang, Dong Hyeon Lee, Meng Sha, Lei Chen, Won Kim, Sang Min Park
- Clin Mol Hepatol. 2025;31(3):1105-1106. Published online July 1, 2025
-
View: 321 Download: 7
- Letter to the Editor
- Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017–2023
- Donghee Kim, Rohit Loomba, Aijaz Ahmed
- Clin Mol Hepatol. 2025;31(3):e235-e238. Published online December 30, 2024
-
View: 1791 Download: 191 Crossref: 3

- What is new in the 2024 Chinese guidelines for fatty liver disease?
- Rui-Xu Yang, Vincent Wai-Sun Wong, Jian-Gao Fan
- Clin Mol Hepatol. 2025;31(3):e239-e246. Published online January 21, 2025
-
View: 905 Download: 68
- Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
- Chi-Kuei Hsu, Po-Yu Huang, Chih-Cheng Lai
- Clin Mol Hepatol. 2025;31(3):e247-e248. Published online February 6, 2025
-
View: 745 Download: 37
- Classification of microvascular invasion of hepatocellular carcinoma: Different standards, common goals: Letter to the editor on “Classification of microvascular invasion of hepatocellular carcinoma: Correlation with prognosis and magnetic resonance imaging”
- Wei Chen, Yihui Rong, Tianshi Ma, Weiwei Shi, Wei Chen, Hang Jiang
- Clin Mol Hepatol. 2025;31(3):e249-e251. Published online February 18, 2025
-
View: 801 Download: 61

- Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
- Weixiong Zhu, Xuefan Zeng, Zengxi Yang, Yusheng Cheng, Wence Zhou
- Clin Mol Hepatol. 2025;31(3):e252-e253. Published online February 26, 2025
-
View: 1098 Download: 62
- Research Letter
- Mendelian randomization does not support the effects of G CSF on decompensated liver disease
- Liling Li, Hui Wang, Hong Wang, Jinchang Huang
- Clin Mol Hepatol. 2025;31(3):e254-e258. Published online March 4, 2025
-
View: 753 Download: 43

- Lipidomic analysis of alcohol use disorder patients revealed the biomarkers for alcohol-related liver disease susceptibility
- Dongyao Wang, Hongwei Zhang, Yuxiao Tang
- Clin Mol Hepatol. 2025;31(3):e259-e262. Published online April 2, 2025
-
View: 755 Download: 62 Crossref: 1

- Non-infectivity of hepatitis B virus under nucleoside analog therapy revealed through auxiliary partial orthotopic liver transplantation
- Xiaojie Chen, Guiwen Guan, Lin Wei, Jidong Jia, Xiangmei Chen, Fengmin Lu, Zhijun Zhu
- Clin Mol Hepatol. 2025;31(3):e263-e267. Published online May 8, 2025
-
View: 529 Download: 42

- Contemporary burden of mortality from chronic liver disease by sex and race/ethnicity in the United States
- Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed
- Clin Mol Hepatol. 2025;31(3):e268-e272. Published online May 8, 2025
-
View: 531 Download: 34

- Hydrophilic and lipophilic statin and clinical outcomes in individuals with alcohol-associated liver disease
- Pojsakorn Danpanichkul, Donghee Kim, Benjamin Nah, Karn Wijarnpreecha, Suthat Liangpunsakul
- Clin Mol Hepatol. 2025;31(3):e273-e276. Published online May 27, 2025
-
View: 419 Download: 17

- Rising drug overdose deaths in chronic liver disease in the United States, 2015–2023
- Donghee Kim, Brittany B Dennis, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed
- Clin Mol Hepatol. 2025;31(3):e277-e280. Published online May 27, 2025
-
View: 438 Download: 22
